News

Filter

1 to 9 of 17 results

Takeda licenses commercial rights to Mersana Fleximer-ADC

27-10-2014

Just seven months after the collaboration was announced, Japan’s largest drugmaker Takeda Pharmaceutical…

BiotechnologyFleximerLicensingMersana TherapeuticsMillennium PharmaceuticalsOncologyTakeda Pharmaceutical

Mersana in deal with Takeda to develop ADCs

Mersana in deal with Takeda to develop ADCs

07-04-2014

Privately-held US biotech firm Mersana Therapeutics has entered into a collaboration agreement with Japanese…

Antibody-drug conjugateBiotechnologyBusiness FinanceHealth Medical PharmaHealth Medical PharmaLicensingMajorMersana TherapeuticsMillennium PharmaceuticalsOncologyResearchTakeda Pharmaceuticals

Strong results from meta-analysis of Takeda's Velcade in multiple myeloma

08-04-2013

Millennium, the USA-based oncology unit of Japan's largest drugmaker Takeda Pharmaceutical (TSE:4502),…

Millennium PharmaceuticalsOncologyPharmaceuticalResearchTakeda PharmaceuticalsVelcade

Infinity amends PI3K-delta, gamma accord with Millennium

28-12-2012

US drug discovery firm Infinity Pharmaceuticals (Nasdaq: INFI) says it has amended its development and…

BiotechnologyFinancialInfinity PharmaceuticalsIPI-145LicensingMillennium PharmaceuticalsPharmaceuticalRespiratory and PulmonaryTakeda Pharmaceuticals

European Commission grants conditional approval for Adcetris

01-11-2012

Millennium, a wholly owned subsidiary of Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502)…

AdcetrisBiotechnologyEuropeMillennium PharmaceuticalsOncologyPharmaceuticalRegulationSeattle GeneticsTakeda Pharmaceuticals

1 to 9 of 17 results

COMPANY SPOTLIGHT

Menarini

Back to top